[1]
2025. Fibrin sealant versus autologous Platelet-Rich Plasma for prevention of seroma after breast cancer surgery: An exploratory randomized controlled trial. Journal of Carcinogenesis. 24, 1s (Feb. 2025), 156–166. DOI:https://doi.org/10.66838/.